Latest filing published 02 Jul 2025 for SpringWorks Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Herschel S. Weinstein, listed as board member, appears in our data through filings on SpringWorks Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 6 January 2022 to 1 July 2025, the count stands at 9 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 2 July 2025: a transaction, in SpringWorks Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations